MI Molecular Intelligence Tumor Seek Test
Comprehensive Cancer Genomic Profiling for Personalized Treatment
The MI Molecular Intelligence Tumor Seek Test represents a groundbreaking advancement in precision oncology, offering comprehensive molecular analysis of tumor tissue to guide personalized cancer treatment strategies. This sophisticated diagnostic tool leverages cutting-edge next-generation sequencing (NGS) technology to provide unprecedented insights into the genetic landscape of cancer, enabling oncologists to make more informed treatment decisions based on the unique molecular characteristics of each patient’s tumor.
What the MI Molecular Intelligence Tumor Seek Test Measures
This comprehensive test analyzes multiple critical molecular markers through advanced genomic sequencing:
- Whole Exome Sequencing (NGS DNA): Comprehensive analysis of all protein-coding regions of the genome to identify somatic mutations, copy number variations, and structural variants that drive cancer progression
- Microsatellite Instability (MSI): Assessment of DNA mismatch repair deficiency, a key biomarker for immunotherapy response prediction
- Tumor Mutational Burden (TMB): Quantification of the total number of mutations per megabase of DNA, helping predict response to immune checkpoint inhibitors
- Whole Transcriptome Sequencing (NGS RNA): Comprehensive analysis of gene expression patterns, fusion transcripts, and alternative splicing events that influence cancer behavior and treatment response
Who Should Consider This Test
The MI Molecular Intelligence Tumor Seek Test is particularly valuable for:
- Patients with advanced or metastatic solid tumors seeking targeted therapy options
- Individuals with rare or difficult-to-treat cancers where standard treatment approaches have been ineffective
- Patients considering immunotherapy who need MSI and TMB status assessment
- Those with cancer recurrence or progression who require new treatment strategies
- Individuals participating in clinical trials requiring comprehensive genomic profiling
- Patients with family history of cancer who want comprehensive molecular characterization
Key Benefits of the MI Molecular Intelligence Tumor Seek Test
- Personalized Treatment Guidance: Identifies specific molecular targets for targeted therapies and immunotherapies
- Comprehensive Analysis: Provides a complete picture of tumor genetics through both DNA and RNA sequencing
- Clinical Trial Matching: Helps identify potential clinical trial opportunities based on molecular profile
- Prognostic Information: Offers insights into disease progression and potential treatment resistance mechanisms
- Family Risk Assessment: May identify hereditary cancer predisposition genes
- Treatment Optimization: Reduces trial-and-error approaches by matching treatments to molecular characteristics
Understanding Your Test Results
Your comprehensive test report will include detailed information about:
- Actionable Mutations: Specific genetic alterations with approved targeted therapies or clinical trial options
- MSI Status: Classification as MSI-high or MSI-stable, with implications for immunotherapy response
- TMB Score: Numerical value indicating tumor mutational burden, categorized as low, intermediate, or high
- Gene Fusions: Identification of fusion transcripts that may be targetable with specific therapies
- Clinical Interpretation: Expert analysis of findings with treatment recommendations and clinical trial matches
- Germline Findings: When appropriate, identification of potential hereditary cancer risk factors
Your oncologist will review the results with you and discuss how the findings may influence your treatment plan, including potential targeted therapies, immunotherapies, or clinical trial opportunities.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $11,700 |
| Regular Price | $13,000 |
| Turnaround Time | 30 Working Days |
| Sample Type | FFPE Tissue Block |
Sample Requirements and Processing
For optimal results, the following sample requirements must be met:
- Sample Type: Formalin fixed paraffin embedded (FFPE) tissue block
- Shipment: Refrigerated transport required
- Tumor Content: Minimum 20% tumor tissue with surface area of at least 25 mm² (5mm x 5mm)
- Required Documentation: Duly filled Tumor Profiling Requisition Form (Form 47) and Histopathology report
- Sample Submission: Daily by 9 AM for processing
Nationwide Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our network of facilities ensures accessible comprehensive cancer genomic testing for patients nationwide.
Take the Next Step in Your Cancer Journey
Don’t leave your treatment decisions to chance. The MI Molecular Intelligence Tumor Seek Test provides the comprehensive molecular information needed to make informed decisions about your cancer treatment. With detailed insights into your tumor’s genetic makeup, you and your healthcare team can develop a personalized treatment strategy that targets the specific molecular drivers of your cancer.
Ready to unlock the power of precision oncology? Book your MI Molecular Intelligence Tumor Seek Test today by calling our dedicated oncology specialists at +1(267) 388-9828 or schedule your consultation through our online booking system.
Take control of your cancer treatment with the most advanced genomic profiling available. Our team of molecular pathologists and genetic counselors are ready to help you navigate your precision medicine journey and provide the insights needed for optimal treatment decisions.
